May. 23 at 2:43 PM
$ADHC GlucoGuard partnership with Dexcom (NASDAQ:
$DXCM), a giant industry leader trading at a
$33B market cap https://x.com/stockpicksnyc/status/1925924845025394752?s=46
Here’s GlucoGuard summary where Dexcom
$DXCM is listed as the CGM developer glucoguardsleep.com/summary/
Also Bill Colone is on the ADHC/GlucoGuard team, he has an insane track record in the medical device field. He’s actually listed as Chairman of advisory board on the GlucoGuard website.
Bill Colone is also the current CEO of SinglePass which recently got FDA clearance for their Kronos biopsy closure device last year.
Bill actually navigated numerous companies through the FDA Approval process
Bill Colone also helped position a surgical vascular graft product company IMPRA Inc which later was ACQUIRED by CR Bard for
$143M Bill was Director of Operations of IMPRA for 11 years.
Also Bill was the active CEO of Endomed when it was ACQUIRED by
$LMAT LeMaitre Vascular, a
$1.8B dollar company
